Profiling the Secretome of Glioblastoma Cells Under Histone Deacetylase Inhibition Using Mass Spectrometry
Glioblastoma (GBM) is the most aggressive brain tumor, and different efforts have been employed in the search for new drugs and therapeutic protocols for GBM. A label-free, mass spectrometry–based quantitative proteomics has been developed to identify and characterize proteins that are differentiall...
Saved in:
Main Authors: | Aline Menezes, Yara Martins, Fábio Nogueira, Denise De Abreu Pereira, Katia Carneiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Bio-protocol LLC
2025-02-01
|
Series: | Bio-Protocol |
Online Access: | https://bio-protocol.org/en/bpdetail?id=5197&type=0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetylation and Histone Deacetylase Inhibitors in Cancer
by: Madeleine S. Q. Kortenhorst, et al.
Published: (2006-01-01) -
Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells
by: Jinpu Yang, et al.
Published: (2017-01-01) -
Inhibition of histone deacetylase in Arabidopsis root calli promotes de novo shoot organogenesis
by: Qinwei Pan, et al.
Published: (2025-01-01) -
Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
by: Androniki Kretsovali, et al.
Published: (2012-01-01) -
Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease
by: Sorabh Sharma, et al.
Published: (2015-01-01)